“Do One Thing” seeks to provide screenings, treatment to underserved communities
A program run by University researchers
aims to quickly identify and provide comprehensive treatment for
medically underserved patients who are chronically infected with the
hepatitis C virus, according to a new study published in the Feb. 14
issue of the Journal of General Internal Medicine.
Hepatitis C — a blood-borne disease that
inflames the liver — is an “underfunded, understudied and seriously
large health problem,” said Amy Nunn, assistant professor of behavioral
and social sciences and medicine, who co-authored the study.
“Its magnitude is not to be
underestimated and there are at least five to seven times as many people
living with hepatitis C than its more infamous counterpart, HIV,” Nunn
said. Unlike for hepatitis A and B, there is no vaccination available
for hepatitis C.
Labels: barriers to treatment, underserved